People
Leadership Philosophy
Wake Forest Infectious Diseases is led by a multidisciplinary team that integrates scientific excellence, clinical leadership, and operational rigor. Our leadership structure reflects the scope of our work—spanning discovery, clinical care, implementation, and public health impact—while ensuring accountability, transparency, and strategic alignment across research and clinical portfolios.
Section Leadership
John Sanders, MD, MPH&TM
Section Chief
Dr. Sanders provides overall strategic and scientific leadership for Wake Forest Infectious Diseases. His role focuses on aligning research excellence with clinical mission, advancing high‑impact scholarship, and fostering partnerships across the health system and public health agencies.
- Scientific vision and research strategy
- Faculty development and mentorship
- Integration of research, clinical care, and public health practice
Aimee Wilkin, MD, MPH
Associate Chief for Clinical Operations
Dr. Wilkin leads clinical operations and ensures that clinical programs, care delivery, and research efforts are cohesively aligned. She plays a central role in translating research insights into clinical workflows and supporting high-quality patient‑centered care.
- Clinical program oversight
- Operational integration across care settings
- Alignment of clinical priorities with research initiatives
Jessica Wells, MD
Fellowship Director
Dr. Wells leads the infectious diseases fellowship program, ensuring that fellows receive the best possible training in infectious diseases.
- Fellowship program oversight
- Fellowship program development
- Fellowship program evaluation
Research & Operations Leadership
Michael E. DeWitt
Research Administrative Leader
Michael DeWitt oversees the strategic coordination, administrative infrastructure, and execution of the Section’s research portfolio. He works closely with faculty, clinical leadership, and institutional partners to ensure that research initiatives are well-supported, compliant, and positioned for impact at scale.
His leadership spans: - Research operations and governance
- Portfolio management across basic, translational, and clinical research
- Interface between investigators, sponsors, and institutional partners
Project Management
Alyssa West, PhD Project Manager – Non‑Clinical Research
Leads project management for basic, translational, computational, public health, and implementation research. Focus areas include milestone tracking, cross‑team coordination, and support for investigator‑initiated studies.
Rica Abbott, MPH Project Manager – Clinical Trials
Provides operational leadership for clinical trials, supporting study start‑up, execution, and close‑out while ensuring adherence to regulatory and institutional requirements.
Clinical Trials Leadership
Caryn Morse, MD, MPH
Medical Director for Clinical Trials
Dr. Morse provides medical and scientific oversight for the clinical trials portfolio. She ensures that trials are conducted with the highest standards of scientific rigor, patient safety, and ethical integrity, while supporting efficient execution within real‑world clinical settings.
- Clinical trial oversight and governance
- Participant safety and protocol integrity
- Integration of trials within routine clinical care
Join Us
Our section includes clinicians, scientists, analysts, trainees, and research professionals working collaboratively across disease areas and methodological domains. We are committed to building a diverse and collaborative community. Opportunities exist for physician faculty, trainees, and staff who are motivated to advance infectious disease research and translate science into practice.
Open Positions
Apply to join the Wake Forest School of Medicine Section on Infectious Diseases:
| Photo | Name | Interests |
|---|---|---|
|
Aimee Wilkin |
HIV, Health Disparities |
|
Amina Ahmed |
Cytomegalovirus, Neonatal Herpes Infection, HIV, Pediatrics, Congenital Infections |
|
Avinash Shetty |
Pediatrics, HIV, Global Health, Emerging Diseases, HPV, Tropical Medicine |
|
Brinkley Raynor Bellotti |
Public Health, Epidemiology, Emerging Diseases, Zoonotic Diseases, Tropical Diseases |
|
Candice J McNeil |
STI, HIV, Public Health |
|
Caryn G Morse |
HIV, Viral Hepatitis, Obesity |
|
Charles de Comarmond |
Tuberculosis, Complicated Urinary Tract Infection, Staphylococcal Infection |
|
Christopher A Ohl |
Antimicrobial Stewardship, Hospital Infections, Emerging Diseases |
|
Erin W Barnes |
Addiction Medicine, OPAT |
|
Jennifer Wenner |
Data Science, Machine Learning, Electronic Health Records, Infectious Disease Epidemiology |
|
Jessica B. Wells |
Medical Education |
|
John C Williamson |
Antimicrobial Stewardship, Pharmacy. Clinical Trials |
|
John W. Sanders |
Infectious Diseases, Tropical Medicine, Vaccine Development |
|
Katherine Schafer |
HIV, LGBTQ Health, Medical Education |
|
Katie Passaretti |
Epidemiology, Hospital Epidemiology, Infection Prevention |
|
Lewis McCurdy |
HIV, STI, Bone and Joint Infections |
|
Luis F Barroso |
HIV, HPV, HRA |
|
Maria Blevins |
Laboratory Science, Vaccine Development |
|
Michael E. DeWitt |
Biostatistics, Bayes, Data Science, One Health, Epidemiology, Ecology, Public Health, Epidemiology, Public Health, Emerging Diseases, Zoonotic Diseases |
|
Michael Leonard |
HIV, Public Health, Tuberculosis |
|
Ryan C Maves |
Sepsis, Immunocompromised Host, Global Health, Respiratory Pathogens, Disaster Planning |
|
Scott Gamble |
Emerging Diseases, Veterinary Science |
|
Thomas Fredick Wierzba |
Enterics, Public Health, Vaccine Development, LMIC |
|
Vera P Luther |
Medical Education |
|
Werner Bischoff |
Epidemiology, Influenza, Infection Prevention, Pathogen Transmission Dynamics |